| abstract |
The phospholipase inhibitors described in the application are chemicalninhibitors of the activity of various phospholipases, in particular enzymes of the typenA2. Said substances can be used in the form of pharmaceuticalsnmeans, which also form part of the solution, to treat conditionsnwhich can be favorably affected by inhibition of phospholipase, in particularnvarious inflammatory conditions. |